Study to assess the clinical consistency of three production lots of GSK Biologicals’ HRV vaccine in terms of immunogenicity and safety when given to healthy infants at 2 and 4 months of age
Rotavirus Vaccine
Infections, Rotavirus
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided. A link to and a NCT ID number is not available for this study because the study was conducted before regulatory requirements to register studies.
January 2014